Omicron variant BA.2.86 spreads faster, but current antivirals hold the line

Researchers discover the BA.2.86 Omicron lineage with higher transmission potential than current dominant strains, yet show that existing antivirals remain effective. Despite its higher infectivity, BA.2.86 exhibits lower pathogenicity in hamsters, indicating decreased replication capacity may lead to less severe infections.

Every Cure and BioPhy Partner to Repurpose Existing Drugs Faster with AI

What You Should Know: – BioPhy, an AI drug development company, and Every Cure, a non-profit dedicated to unlocking the potential of existing drugs for

May 3, 2024

In stunning outcome, Amylyx’s ALS drug fails large clinical trial

Amylyx Pharmaceuticals said Friday that its treatment for ALS, called Relyvrio, failed to provide any benefit for patients in a large clinical trial — a

March 8, 2024

Young Cervical Cancer, Leukemia Survivors at Greater Risk of Obstetric Complications

Young women who survived cervical cancer and leukemia were less likely to give birth and, when they did, sustained greater risk of serious obstetric complications,

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.